Back to results
CompletedPhase 4

Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy

NCT06224790

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

King Edward Medical University

Lahore, Punjab Province, Pakistan

View on ClinicalTrials.gov
Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy — TrialFind